Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2026-03-29 @ 11:18 AM
Study NCT ID:
NCT00544804
Status:
COMPLETED
Last Update Posted:
2014-07-02
First Post:
2007-10-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Sponsor:
University of California, San Francisco
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UCSF-077518
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |